A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
K36 Therapeutics, Inc.
Alterome Therapeutics, Inc.
M.D. Anderson Cancer Center
Elevation Oncology
University of Pittsburgh
Plus Therapeutics
Engeneic Pty Limited
Advanced Accelerator Applications
Revolution Medicines, Inc.
Endocyte